Rifampicin is not an activator of the glucocorticoid receptor in A549 human alveolar cells

Molecular Pharmacology

Volumn 55, Issue 5, 1999, Pages 841-846

  Jaffuel, Dany ^a   Demoly, Pascal ^a,b   Gougat, Claire ^a   Mautino, Gisèle ^a   Bousquet, Jean ^a   Mathieu, Marc ^a  

^a INSERM   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RANTES; RIFAMPICIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TRANSACTIVATION;

EID: 0032906550     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Barnes D, Tse J, Kaufhold M, Owen M, Hesselgesser J, Strieter R, Horuk R and Perez H (1998) Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J Clin Invest 101:2910-2919.
2. Berrebi D, Banerjee A, Paris R, Potet F, Aigrain Y, Emilie D, Cezard J, Hugot J, Navarro J and Peuchmaur M (1997) In situ Rantes and interferon-gamma gene expression in pediatric small bowel Crohn's disease. J Pediatr Gastroenterol Nutr 25:371-376.
3. Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Backman M, Ohlsson R, Postlind H, Blomquist P and Berkenstam A (1998) Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 95:12208-12213.
4. Blanchard J (1998) The ying and yang of rifampicin. Nat Med 4:14-15.
5. Boman G and Malmborg A (1974) Rifampicin in plasma and pleural fluid after single oral doses. Eur J Clin Pharmacol 7:51-58.
6. Calleja C, Pascussi J, Mani J, Maurel P and Vilarem M (1998) The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocortcoid receptor. Nat Med 4:92-96.
7. Cato A and Wade E (1996) Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 18:371-378.
8. Chen S, Bacon K, Li L, Garcia G, Xia Y, Lo D, Thompson D, Siani M, Yamamoto T, Harrison J and Feng L (1998) In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med 188:193-198.
9. Cocchi F, DeVico A, Garzino-Demo A, Arya S, Gallo R and Lusso P (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science (Washington DC) 270:1811-1815.
10. Dooley D, Carpenter J and Rademacher S (1997) Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 25:872-887.
11. Glabinski A, Tuohy V and Ransohoff R (1998) Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation 5:166-171.
12. Gonzalo J, Lloyd C, Wen D, Albar J, Wells T, Proudfoot A, Martinez A, Dorf M, Bjerke T, Coyle A and Gutierrez-Ramos J (1998) The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 188:157-167.
13. Graham F, Smiley J, Russell W and Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-74.
14. Guo D, Uno S, Ishihata A, Nakamura N and Inagami T (1995) Identification of a cis-acting glucocorticoid responsive element in the rat angiotensin II type 1A promoter. Circ Res 77:249-257.
15. Halsey N, Coberly J, Desormeaux J, Losikoff P, Moulton L, Contave M, Johnson M, Davis H, Geiter L, Johnson E, Huebner R, Boulos R and Chaisson R (1998) Randomized trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet 351:786-792.
16. Houston S and Fanning A (1994) Current and potential treatment of tuberculosis. Drugs 48:689-708.
17. Imai E, Miner J, Mitchell J, Yamamoto K and Granner D (1993) Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 268:5353-5356.
18. Jantzen H, Strahle U, Gloss B, Stewart F, Schmid W, Boshart M, Miksicek R and Schutz G (1987) Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 49:29-38.
19. Jonat C, Rahmsdorf HJ, Park K-K, Cato ACB, Gebel S, Ponta H and Herrlich P (1990) Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-1204.
20. Kavallaris M, Kuo D, Burkhart C, Regl D, Norris M, Haber M and Horwitz S (1997) Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific-tubulin isotypes. J Clin Invest 100:1282-1293.
21. Kiss I, Farago E, Juhaz I, Basca S and Fabian E (1976) Investigation on the serum and lung tissue level of rifampicin in man. Int J Clin Pharmacol Biopharm 13:42-47.
22. Kohout T, O'Brian J, Gaa S, Lederer W and Rogers T (1996) Novel adenovirus component system that transfects cultured cardiac cells with high efficiency. Circ Res 78:971-977.
23. Kwon OJ, Jose PJ, Robbins RA, Schall TJ, Williams TJ and Barnes PJ (1995) Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol 12:488-496.
24. Mathieu M, Gougat C, Jaffuel D, Danielsen M, Godard P, Bousquet J and Demoly P (1999) The glucocorticoid receptor gene as a candidate for gene therapy in asthma. Gene Ther 6:245-252.
25. Mehta P, King C, White E, Murtagh JJ and Quinn F (1996) Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication. Infect Immun 64:2673-2679.
26. Ming M, Chan W, Wang T, Roberts K, Bouvier M, Lachance S, Carriere S and Chan J (1996) Beta-adrenoceptors and dexamethasone synergistically stimulate the expression of the angiotensinogen gene in opossum kidney cells. Kidney Int 50: 94-101.
27. Naumann M, Wulczyn F and Scheidereit C (1993) The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B. EMBO J 12:213-222.
28. Nelson P, Kim H, Manning W, Goralski T and Krensky A (1993) Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 151:2601-2612.
29. Nguyen T, Chen P, Huang W, Chen H, Johnson D and Polansky J (1998) Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem 273:6341-6350.
30. Qi M, Stasenko L and DeFranco D (1990) Recycling and desensitization of glucocorticoid receptors in v-mos transformed cells depend on the ability of nuclear receptors to modulate gene expression. Mol Endocrinol 4:455-464.
31. Raviglione M, Snider D and Kochi A (1995) Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. J Am Med Assoc 273:220-226.
32. Ray D, Lovering A, Davis J and White A (1998) Rifampicin: a glucocorticoid receptor ligand (Letter)? Nat Med 4:1090-1091.
33. Roux P, Verrier B, Klein B, Niccolino M, Marty L, Alexandra C and Piechaczyk M (1991) Retrovirus-mediated gene transfer of a human c-fos cDNA into mouse bone marrow stromal cells. Oncogene 6:2155-2160.
34. Sadek M, Sada E, Toossi Z, Schwander S and Rich E (1998) Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol 19:513-521.
35. Scarlatti G, Tresoldi E, Bjorndal A, Fredriksson R, Colognesi C, Deng H, Malnati M, Plebani A, Siccardi A, Littman D, Fenyo E and Lusso P (1997) In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 3:1259-1265.
36. Schuetz J, Schuetz E, Thottassery J, Guzelian P, Strom S and Sun D (1996) Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Mol Pharmacol 49:63-72.
37. Senderovitz T and Viskum K (1994) Corticosteroids and tuberculosis. Respir Med 88:561-565.
38. Venge J, Lampinen M, Hakansson L, Rak S and Venge P (1996) Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol 97:1110-1115.